Previous Close | 75.46 |
Open | 75.49 |
Bid | 75.70 x 100 |
Ask | 76.03 x 100 |
Day's Range | 75.13 - 75.86 |
52 Week Range | 62.58 - 85.62 |
Volume | |
Avg. Volume | 540,986 |
Market Cap | 4.393B |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | 46.81 |
EPS (TTM) | 1.62 |
Earnings Date | Apr 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 94.22 |
Subscribe to Yahoo Finance Plus to view Fair Value for MMSI
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical (MMSI) announces the launch of its latest FDA-approved Micro ACE Advanced Micro-Access System, which is likely to benefit interventional treatments using micro access.
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging casesSOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. Merit also intends to file Micro ACE for CE mark designation. The Micro ACE system is the latest innovation in t